slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 61,141-61,170
Pages 3,679
Rows per page 30
Component
61,141-61,170 of 110,355
41
Includes a clinical trial flow diagram and endpoint table. Mentions strategic collaboration with GSK.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
45
Includes a biological pathway diagram illustrating the signaling cascade.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
49
The background features a DNA-like sequence pattern (A, T, C, G) on a gradient background.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
50
23andMe | Investor Presentation Deck | 63 slides23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
51
The slide uses a split-screen layout with a blue gradient background on the left and financial metrics on the right.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
52
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
54
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
59
The slide uses a 2-column layout to contrast established metrics with future/status indicators.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
62
The slide highlights a $300M investment and 50/50 profit sharing model.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
07
Includes adjustments for litigation, tax payments, and restructuring.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations 1 hit
40
The slide uses a timeline format to communicate long-term sustainability commitments and investment plans.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
41
Uses a chevron-style separator to imply a process or causal link between the left and right lists.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
44
The slide uses a donut chart to visualize revenue distribution across four sub-segments.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
52
The slide uses a 3-column layout for market segments and a 4-item numbered list for strategic imperatives.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
54
The slide uses a three-column layout to detail strategic pillars, each with a numbered header, bulleted list, descriptive text, and visual evidence (photos or chart).3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
55
The slide uses a process-based framework (Prevent, Prepare, Protect, Activate, Close) to categorize the product portfolio.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
58
The slide uses a donut chart to visualize revenue distribution across six sub-segments.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
66
The slide uses a 3-column layout for market segments and a numbered list for strategic imperatives.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
80
The slide highlights capital allocation strategy and debt management.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
10
The chart uses a box plot to visualize the distribution of royalty rates across two time periods.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
12
The chart uses a logarithmic-style vertical axis to show potency differences, with Bebtelovimab as the baseline.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
16
The slide provides a snapshot of the company's clinical pipeline as of February 24, 2022.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
01
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
06
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
07
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
08
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Key Messages1 hit
11
The slide uses a timeline framework to map clinical events against age in years.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Patient Medical History1 hit
13
The slide uses a before-after framework to demonstrate the efficacy of the treatment plan.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Diagnostic Methods and Biochemistry Labs1 hit
14
The chart tracks patient data from 2007 to 2021 with specific clinical annotations explaining fluctuations.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
16
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Summary and Conclusions1 hit